The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 29th Oct 2013 08:48

Adept Telecom: Northland Capital revises target price from 145p to 165p and reiterates a buy recommendation.Aggreko: JP Morgan reduces target price from 1620p to 1505p, while its neutral recommendation remains unchanged. UBS cuts target price from 1610p to 1555p keeping its neutral rating.APR Energy: Investec raises target price from 900p to 1150p and stays with its hold recommendation.ARM Holdings: RBC Capital moves target price from 1050p to 1080p and retains an outperform rating.Barratt Developments: Liberum Capital ups target price from 374p to 387p and maintains a buy recommendation.Bellway: Liberum Capital takes target price from 1700p to 1760p and retains its buy recommendation.Berkeley Group: Liberum Capital raises target price from 2400p to 2634p, while reiterating a hold recommendation.Blur Group: Liberum Capital raises target price from 400p to 700p and stays with its buy recommendation.Bovis Homes Group: Liberum Capital increases target price from 791p to 911p upgrading to buy.Braemer Shipping Services: Westhouse Securities takes target price from 515p to 590p and reiterates an add rating.BT Group: Bank of America ups target price from 350p to 400p retaining a buy recommendation.Coca-Cola HBC: Nomura reduces target price from 1600p to 1500p and downgrades from neutral to reduce.EMIS Group: N+1 Singer takes target price to 748p upgrading from hold to buy.Europa Oil & Gas: Northland Capital shifts target price from 17.60p to 19.70p and stays with its buy recommendation.Genel Energy: RBC Capital revises target price from 1100p to 1300p and maintains an outperform rating.Getech: WH Ireland shifts target price from 86p to 92p staying with its buy recommendation.GlaxoSmithKline: Barclays lowers target price from 1555p to 1545p and retains an equal-weight rating.Halfords Group: Investec ups target price from 400p to 460p and maintains its buy recommendation.HSBC Holdings: Goldman Sachs cuts target price from 950p to 900p, while reiterating its strong buy recommendation.ITV: Berenberg raises target price from 91p to 155p, but downgrades from hold to sell.Kirkland Lake Gold: Investec cuts target price from 377p to 353p, while its buy recommendation is kept.Lloyds Banking Group: Goldman Sachs shifts target price from 75p to 76p and maintains a neutral rating. Numis downgrades to hold with a target price of 85p.Microgen: Investec lowers target price from 147p to 143p and keeps a hold recommendation. Westhouse Securities cuts target price from 155p to 145p, while upgrading to add.Next Fifteen Communications: Canaccord Genuity reduces target price from 120p to 94p downgrading from buy to hold.Persimmon: Liberum Capital takes target price from 1245p to 1261p, while its hold recommendation remains unaltered.Playtech: Investec places its target price (prev.: 630p) under review, while staying with its hold recommendation. Canaccord Genuity raises target price from 780p to 825p retaining its buy recommendation. Daniel Stewart increases target price from 790p to 840p and keeps its buy recommendation.Redrow: Liberum Capital ups target price from 241p to 304p and upgrades to buy.Regus: Investec downgrades from buy to add with a target price of 205p.Salamander Energy: RBC Capital cuts target price from 250p to 170p downgrading to neutral.Shire: Barclays increases target price from 2515p to 2800p, while its overweight rating is kept.Stagecoach: Investec places its target price (prev.: 325p) under review, while leaving its add rating unchanged.Standard Chartered: Goldman Sachs reduces target price from 1900p to 1700p leaving its neutral rating unaltered.Taylor Wimpey: Liberum Capital moves target price from 113p to 127p and keeps a buy recommendation.
More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.